Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 3547096, 11 pages
http://dx.doi.org/10.1155/2016/3547096
Research Article

WISP1 Is Increased in Intestinal Mucosa and Contributes to Inflammatory Cascades in Inflammatory Bowel Disease

Department of Gastroenterology, The Affiliated Hospital of Qingdao University, Qingdao 266003, China

Received 21 January 2016; Revised 11 May 2016; Accepted 11 May 2016

Academic Editor: Stamatios Theocharis

Copyright © 2016 Qi Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Asakura, K. Suzuki, and T. Honma, “Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?” World Journal of Gastroenterology, vol. 13, no. 15, pp. 2145–2149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. B. R. R. de Mattos, M. P. G. Garcia, J. B. Nogueira et al., “Inflammatory bowel disease: an overview of immune mechanisms and biological treatments,” Mediators of Inflammation, vol. 2015, Article ID 493012, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Di Sabatino, M. V. Lenti, P. Giuffrida, A. Vanoli, and G. R. Corazza, “New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract,” Autoimmunity Reviews, vol. 14, no. 12, pp. 1161–1169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. N. Ananthakrishnan, H. Khalili, G. G. Konijeti et al., “Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease,” Gut, vol. 63, no. 5, pp. 776–784, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Ko, V. Kariyawasam, M. Karnib et al., “Inflammatory bowel disease environmental risk factors: a population-based case-control study of middle Eastern Migration to Australia,” Clinical Gastroenterology and Hepatology, vol. 13, no. 8, pp. 1453–1463.e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. C. Ng, W. Tang, R. W. Leong et al., “Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific,” Gut, vol. 64, no. 7, pp. 1063–1071, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Tailor, L. Faulkner, D. J. Naisbitt, and B. K. Park, “The chemical, genetic and immunological basis of idiosyncratic drug-induced liver injury,” Human & Experimental Toxicology, vol. 34, no. 12, pp. 1310–1317, 2015. View at Publisher · View at Google Scholar
  8. W. Strober and I. J. Fuss, “Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases,” Gastroenterology, vol. 140, no. 6, pp. 1756–1767, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Liu, B.-S. Feng, S.-B. Yang, X. Chen, J. Su, and P.-C. Yang, “Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease,” The Journal of Biological Chemistry, vol. 287, no. 5, pp. 3591–3597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Liu, P. K. Yadav, X. Xu et al., “The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity,” Journal of Leukocyte Biology, vol. 89, no. 4, pp. 597–606, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Strober, I. Fuss, and P. Mannon, “The fundamental basis of inflammatory bowel disease,” The Journal of Clinical Investigation, vol. 117, no. 3, pp. 514–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-C. Chen and L. F. Lau, “Functions and mechanisms of action of CCN matricellular proteins,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 4, pp. 771–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Pennica, T. A. Swanson, J. W. Welsh et al., “WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14717–14722, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Berschneider and M. Königshoff, “WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease,” The International Journal of Biochemistry & Cell Biology, vol. 43, no. 3, pp. 306–309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. F. Calvisi, E. A. Conner, S. Ladu, E. R. Lemmer, V. M. Factor, and S. S. Thorgeirsson, “Activation of the canonical Wnt/β-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer,” Journal of Hepatology, vol. 42, no. 6, pp. 842–849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Margalit, L. Eisenbach, N. Amariglio et al., “Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines,” British Journal of Cancer, vol. 89, no. 2, pp. 314–319, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Xie, K. Nakachi, H. Wang, R. Elashoff, and H. P. Koeffler, “Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features,” Cancer Research, vol. 61, no. 24, pp. 8917–8923, 2001. View at Google Scholar · View at Scopus
  18. H. Y. Wang, R. Zhang, S. B. Wen, D.-M. McCafferty, P. L. Beck, and W. K. MacNaughton, “Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis,” Journal of Molecular Medicine, vol. 87, no. 4, pp. 435–445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. P. Morris, P. L. Beck, M. S. Herridge, W. T. Depew, M. R. Szewczuk, and J. L. Wallace, “Hapten-induced model of chronic inflammation and ulceration in the rat colon,” Gastroenterology, vol. 96, no. 3, pp. 795–803, 1989. View at Google Scholar · View at Scopus
  20. M. F. Neurath, I. Fuss, B. L. Kelsall, E. Stüber, and W. Strober, “Antibodies to interleukin 12 abrogate established experimental colitis in mice,” The Journal of Experimental Medicine, vol. 182, no. 5, pp. 1281–1290, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. M. F. Neurath, S. Pettersson, K.-H. M. Zum Buschenfelde, and W. Strober, “Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice,” Nature Medicine, vol. 2, no. 9, pp. 998–1004, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Posevitz-Fejfár, V. Posevitz, C. C. Gross et al., “Effects of blood transportation on human peripheral mononuclear cell yield, phenotype and function: implications for immune cell biobanking,” PLoS ONE, vol. 9, no. 12, Article ID e115920, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Monteleone, L. Biancone, R. Marasco et al., “Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells,” Gastroenterology, vol. 112, no. 4, pp. 1169–1178, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Wu, M. M. Sun, H.-P. Zhang et al., “Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation,” Gut, vol. 63, no. 12, pp. 1883–1892, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Liu, K. Geboes, S. Colpaert et al., “Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions,” The Journal of Immunology, vol. 164, no. 11, pp. 6005–6014, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Picarella, P. Hurlbut, J. Rottman, X. Shi, E. Butcher, and D. J. Ringler, “Monoclonal antibodies specific for β7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells,” Journal of Immunology, vol. 158, no. 5, pp. 2099–2106, 1997. View at Google Scholar · View at Scopus
  27. M. Z. Cader and A. Kaser, “Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation,” Gut, vol. 62, no. 11, pp. 1653–1664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Caruso, I. Marafini, E. Franzè et al., “Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut,” Mucosal Immunology, vol. 7, no. 6, pp. 1467–1479, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. I. J. Fuss, M. Neurath, M. Boirivant et al., “Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5,” The Journal of Immunology, vol. 157, no. 3, pp. 1261–1270, 1996. View at Google Scholar
  30. S. Brand, “Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease,” Gut, vol. 58, no. 8, pp. 1152–1167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Monteleone, I. Monteleone, D. Fina et al., “Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn's disease,” Gastroenterology, vol. 128, no. 3, pp. 687–694, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. F. Neurath, “Cytokines in inflammatory bowel disease,” Nature Reviews Immunology, vol. 14, no. 5, pp. 329–342, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S. H. Lee, “Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases,” Intestinal Research, vol. 13, no. 1, pp. 11–18, 2015. View at Publisher · View at Google Scholar
  34. J. Däbritz and T. R. Menheniott, “Linking immunity, epigenetics, and cancer in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 20, no. 9, pp. 1638–1654, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. Brigstock, R. Goldschmeding, K.-I. Katsube et al., “Proposal for a unified CCN nomenclature,” Molecular Pathology, vol. 56, no. 2, pp. 127–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. B. Blom, S. M. Brockbank, P. L. Van Lent et al., “Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1,” Arthritis and Rheumatism, vol. 60, no. 2, pp. 501–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Königshoff, M. Kramer, N. Balsara et al., “WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis,” The Journal of Clinical Investigation, vol. 119, no. 4, pp. 772–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. J. I. Jun and L. F. Lau, “The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing,” Nature Cell Biology, vol. 12, pp. 676–685, 2010. View at Publisher · View at Google Scholar
  39. C. A. Inkson, M. Ono, S. A. Kuznetsov, L. W. Fisher, P. G. Robey, and M. F. Young, “TGF-β1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function,” Journal of Cellular Biochemistry, vol. 104, no. 5, pp. 1865–1878, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. D. M. French, R. J. Kaul, A. L. D'Souza et al., “WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair,” American Society for Investigative Pathology, vol. 165, no. 3, pp. 855–867, 2004. View at Google Scholar